Skip to main content

Table 2 Changes in CAT and mMRC scores from baseline to the end of the study period

From: Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study

  Baseline
(n = 36)
End
(n = 36)
P value
CAT 12.31 ± 7.79 4.39 ± 3.20 <  0.0001
mMRC 2.53 ± 1.48 1.17 ± 0.83 <  0.0001
  1. Data are presented as mean ± SD. The study period was 26 ± 2 weeks. Abbreviations: CAT chronic obstructive pulmonary disease assessment test, mMRC Modified Medical Research Council dyspnea scale